Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0060
-0.0010 (-14.29%)
Aug 28, 2025, 3:00 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 19.04 million as of August 28, 2025. Its market cap has increased by 100.26% in one year.
Market Cap
19.04M
Enterprise Value
17.74M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has decreased from 39.36M to 19.04M, a decrease of -51.62%. That is a compound annual growth rate of -2.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 22.21M | 180.37% |
| Dec 31, 2024 | 7.92M | -28.57% |
| Dec 29, 2023 | 11.09M | -59.76% |
| Dec 30, 2022 | 27.57M | 0.10% |
| Dec 30, 2021 | 27.54M | -40.60% |
| Dec 31, 2020 | 46.37M | 634.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 104.18B |
| Pro Medicus | 31.60B |
| Cochlear | 19.73B |
| Sonic Healthcare | 11.89B |
| Ramsay Health Care | 8.78B |
| Telix Pharmaceuticals | 6.41B |
| Ansell | 4.98B |
| Mesoblast | 3.15B |